Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Acquired by Financial Partners Group LLC

Financial Partners Group LLC lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.6% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 58,317 shares of the pharmacy operator’s stock after acquiring an additional 2,021 shares during the period. Financial Partners Group LLC’s holdings in Walgreens Boots Alliance were worth $1,265,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Highlander Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter worth about $26,000. Pineridge Advisors LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter worth about $26,000. Venturi Wealth Management LLC increased its position in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter worth about $30,000. Finally, Quest Partners LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter worth about $30,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. SVB Leerink dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research report on Monday, March 18th. Truist Financial lowered their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday. UBS Group lowered their price target on Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, June 24th. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $20.64.

Walgreens Boots Alliance Stock Down 0.8 %

Shares of WBA traded down $0.09 during trading on Friday, reaching $12.10. The company’s stock had a trading volume of 54,346,456 shares, compared to its average volume of 17,649,060. The company has a fifty day moving average of $16.49 and a two-hundred day moving average of $20.14. Walgreens Boots Alliance, Inc. has a twelve month low of $11.68 and a twelve month high of $31.32. The company has a market cap of $10.43 billion, a price-to-earnings ratio of -1.79, a P/E/G ratio of 0.84 and a beta of 0.78. The company has a quick ratio of 0.32, a current ratio of 0.65 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same period in the previous year, the company earned $1.00 earnings per share. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 2.94 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.27%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.